Regeneron Pharmaceuticals (REGN) Free Cash Flow Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 31.42% |
| 10 | Revolution Medicines | 37.23 Bn | 37.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.65% |
| Dec 31, 2025 | -16.22% |
| Sep 30, 2025 | 33.13% |
| Jun 30, 2025 | 42.75% |
| Mar 31, 2025 | -25.34% |
| Dec 31, 2024 | -21.73% |
| Sep 30, 2024 | -35.35% |
| Jun 30, 2024 | -8.41% |
| Mar 31, 2024 | 32.42% |
| Dec 31, 2023 | -7.80% |
| Sep 30, 2023 | 55.68% |
| Jun 30, 2023 | 11.42% |
| Mar 31, 2023 | 31.10% |
| Dec 31, 2022 | 34.22% |
| Sep 30, 2022 | 3.75% |
| Jun 30, 2022 | 63.67% |
| Mar 31, 2022 | 33.56% |
| Dec 31, 2021 | 51.06% |
| Sep 30, 2021 | 111.51% |
| Jun 30, 2021 | 15.70% |